Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pulmonx (LUNG) Shares Outstanding (Diluted Average) (2020 - 2025)

Pulmonx has reported Shares Outstanding (Diluted Average) over the past 6 years, most recently at $40.9 million for Q3 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 5.09% to $40.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $40.9 million through Sep 2025, up 5.09% year-over-year, with the annual reading at $39.1 million for FY2024, 2.99% up from the prior year.
  • Shares Outstanding (Diluted Average) was $40.9 million for Q3 2025 at Pulmonx, up from $40.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $40.9 million in Q3 2025 and troughed at $35.4 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $37.8 million (2023), against an average of $37.9 million.
  • Year-over-year, Shares Outstanding (Diluted Average) surged 1744.99% in 2021 and then grew 1.51% in 2022.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $36.1 million in 2021, then grew by 2.68% to $37.1 million in 2022, then rose by 2.37% to $38.0 million in 2023, then grew by 2.99% to $39.1 million in 2024, then increased by 4.67% to $40.9 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Shares Outstanding (Diluted Average) are $40.9 million (Q3 2025), $40.4 million (Q2 2025), and $40.0 million (Q1 2025).